data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Sarepta Therapeutics
(NASDAQ:SRPT)
$75.71
0.75[1.00%]
At close: Jul 1
$75.71
00
After Hours: 4:11PM EDT
Day High/Low73.55 - 76.34
52 Week High/Low61.28 - 101.24
Open / Close74.57 / 75.71
Float / Outstanding83.6M / 87.5M
Vol / Avg.884.9K / 744.2K
Mkt Cap6.6B
P/E-
50d Avg. Price70.73
Div / Yield-
Payout Ratio-
EPS-1.2
Total Float83.6M

Sarepta Therapeutics (NASDAQ:SRPT), Quotes and News Summary

Sarepta Therapeutics (NASDAQ: SRPT)

Day High/Low73.55 - 76.34
52 Week High/Low61.28 - 101.24
Open / Close74.57 / 75.71
Float / Outstanding83.6M / 87.5M
Vol / Avg.884.9K / 744.2K
Mkt Cap6.6B
P/E-
50d Avg. Price70.73
Div / Yield-
Payout Ratio-
EPS-1.2
Total Float83.6M
Benzinga - Jun 24, 2022, 9:55AM
Benzinga - Jun 24, 2022, 7:38AM
Benzinga - Jun 23, 2022, 4:44PM
Benzinga - Jun 23, 2022, 4:02PM
Benzinga - Jun 13, 2022, 7:33AM
Benzinga - May 24, 2022, 10:17AM
Benzinga - May 19, 2022, 9:15AM
Benzinga - May 4, 2022, 4:50PM
Benzinga - Apr 12, 2022, 10:21AM
Benzinga - Apr 6, 2022, 3:48PM
Benzinga - Apr 4, 2022, 1:35PM
Benzinga - Mar 7, 2022, 8:39AM
Benzinga - Mar 2, 2022, 11:49AM
Benzinga - Mar 2, 2022, 7:42AM
Benzinga - Mar 1, 2022, 4:31PM
Benzinga - Feb 1, 2022, 11:28AM
Benzinga - Feb 1, 2022, 9:05AM
Benzinga - Feb 1, 2022, 8:10AM
load more
Sector: Health Care.Industry: Biotechnology
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-1.270-0.560 0.7100
REV206.440M210.830M4.390M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Sarepta Therapeutics Questions & Answers

Q
How do I buy Sarepta Therapeutics (SRPT) stock?
A

You can purchase shares of Sarepta Therapeutics (NASDAQ: SRPT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Sarepta Therapeutics's (SRPT) competitors?
Q
What is the target price for Sarepta Therapeutics (SRPT) stock?
A

The latest price target for Sarepta Therapeutics (NASDAQ: SRPT) was reported by Cantor Fitzgerald on Friday, June 24, 2022. The analyst firm set a price target for 128.00 expecting SRPT to rise to within 12 months (a possible 69.07% upside). 21 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Sarepta Therapeutics (SRPT)?
A

The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $75.71 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Sarepta Therapeutics (SRPT) pay a dividend?
A

There are no upcoming dividends for Sarepta Therapeutics.

Q
When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?
A

Sarepta Therapeutics’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is Sarepta Therapeutics (SRPT) going to split?
A

There is no upcoming split for Sarepta Therapeutics.

Q
What sector and industry does Sarepta Therapeutics (SRPT) operate in?
A

Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.